IP Library Granted Patent US 12,351,773
Granted Patent B2
US 12,351,773 · App. 17/422,363 · Granted Jul 8, 2025

Lubricious thermoplastic compounds and thermoplastic articles made therefrom

Inventors: Qing Ge (Solon, OH); Jing Liu (Avon, OH)
Assignee: Avient Corporation
C10M107/44A61L29/085C10M107/34C10M107/42C10M125/22C10M169/04C10M2201/084C10M2209/1045C10M2217/0285C10M2217/0443C10M2217/0453C10N2040/50C10N2050/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,351,773
App. No.
17/422,363
Granted
Jul 8, 2025
Kind
B2
Abstract

Lubricious thermoplastic articles are formed from thermoplastic compounds including (a) thermoplastic elastomer selected from thermoplastic polyurethane, polyether block amide, and combinations thereof; and (b) from about 5 to about 20 weight percent, by weight of the compound, of hydrophilic water-insoluble polymer selected from polyolefin-polyoxyalkylene block copolymer, crosslinked polyvinylpyrrolidone, and combinations thereof. The thermoplastic compounds are capable of providing enhanced lubricity in the thermoplastic articles without significant degradation in mechanical properties such as elongation and tensile strength, as compared to thermoplastic articles formed from the neat thermoplastic elastomer and subjected to the same heat processing history.

Claims (18)

1. A lubricious thermoplastic article formed from a thermoplastic compound comprising:

(a) thermoplastic elastomer that is thermoplastic polyurethane; and

(b) from about 5 to about 20 weight percent, by weight of the compound, of hydrophilic water-insoluble polymer that is crosslinked polyvinylpyrrolidone;

wherein the crosslinked polyvinylpyrrolidone is a powder having a particle size distribution wherein at least 95% of particles have a particle size of less than 250 micrometers; and

the crosslinked polyvinylpyrrolidone is crosslinked prior to inclusion into the thermoplastic compound.

2. The article of claim 1 , wherein the hydrophilic water-insoluble polymer consists of crosslinked polyvinylpyrrolidone.

3. The article of claim 1 , wherein the article has a Relative Dynamic COF of less than about 0.9.

4. The article of claim 3 , wherein the article has at least one of a Relative Tensile Strength at Break of greater than about 0.8 and a Relative Elongation at Break of greater than about 0.8.

5. The article of claim 1 , wherein the article has a Relative Dynamic COF of less than about 0.6, and wherein the article has at least one of a Relative Tensile Strength at Break of greater than about 1 and a Relative Elongation at Break of greater than about 1.

6. The article of claim 1 , wherein the article has a Relative Dynamic COF (Wet) of less than about 0.5, and wherein the article has both a Relative Tensile Strength at Break of greater than about 1 and a Relative Elongation at Break of greater than about 1.

7. The article of claim 1 , wherein the thermoplastic compound further comprises one or more additives selected from the group consisting of antimicrobial agents; antioxidants and stabilizers; colorants; radiopaque agents; and combinations thereof.

8. The article of claim 1 , wherein the article is a catheter.

9. A method of making the article of claim 1 , the method comprising the steps of:

(a) providing ingredients comprising the thermoplastic elastomer and the hydrophilic water-insoluble polymer;

(b) melt mixing the ingredients to provide the thermoplastic elastomer compound; and

(c) forming the thermoplastic elastomer compound to provide the article for the intended use without a subsequent step of applying a lubricity enhancing agent to the article prior to the intended use.

10. The method of claim 9 , wherein the step of forming comprises extruding the thermoplastic elastomer compound.

11. The method of claim 9 , further comprising the step of inserting the article into a human body.

Assignments (4)
RELEASE OF SECURITY INTERESTS IN PATENTS RECORDED AT REEL 067697, FRAME 0369. Recorded Jun 24, 2025
From: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
To: AVIENT CORPORATION; COLORMATRIX HOLDINGS, INC.
Reel/Frame 071708/0376 →
SECURITY AGREEMENT Recorded Jun 12, 2025
From: AVIENT CORPORATION; COLORMATRIX HOLDINGS, INC.; COLORMATRIX GROUP, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 071574/0571 →
PATENT SECURITY AGREEMENT (TERM) Recorded Jun 12, 2024
From: AVIENT CORPORATION; COLORMATRIX HOLDINGS, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 067699/0676 →
SECURITY INTEREST Recorded Jun 11, 2024
From: AVIENT CORPORATION; COLORMATRIX HOLDINGS, INC.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 067697/0369 →
Continuity (2)
Provisional Application 62792497 · Jan 15, 2019
Related Publication 20220119724A1 · Apr 21, 2022
References Cited (37)
US 4781703A · Walker · 1988 [cited by examiner]
US 4883699A · Aniuk · 1989 [cited by examiner]
US 5001009A · Whitbourne · 1991 [cited by applicant]
US 5061424A · Karimi · 1991 [cited by examiner]
US 20020045049A1 · Madsen · 2002 [cited by examiner]
US 20060240060A1 · Bavaro · 2006 [cited by applicant]
US 20070287800A1 · Acquarulo et al. · 2007 [cited by applicant]
US 20090041923A1 · Lin et al. · 2009 [cited by applicant]
US 20100136073A1 · Preuss et al. · 2010 [cited by applicant]
US 20100209472A1 · Wang · 2010 [cited by examiner]
US 20100217186A1 · Nazarova et al. · 2010 [cited by applicant]
US 20120046411A1 · Kulshrestha et al. · 2012 [cited by applicant]
US 20120132457A1 · Tai et al. · 2012 [cited by applicant]
US 20120322348A1 · Yokoi et al. · 2012 [cited by applicant]
US 20150218354A1 · Kulshrestha et al. · 2015 [cited by applicant]
US 20160022877A1 · Gravesen · 2016 [cited by examiner]
US 20160220735A1 · Frautschi · 2016 [cited by examiner]
US 20180036516A1 · Wang · 2018 [cited by applicant]
US 20190224384A1 · Lundahl et al. · 2019 [cited by applicant]
CN 101222946A · 2008 [cited by applicant]
CN 101883813A · 2010 [cited by applicant]
CN 102438670A · 2012 [cited by applicant]
CN 102639160A · 2012 [cited by applicant]
CN 103041454A · 2013 [cited by applicant]
CN 107405430A · 2017 [cited by applicant]
CN 107698952A · 2018 [cited by applicant]
CN 108430528A · 2018 [cited by applicant]
EP 2174982A2 · 2010 [cited by applicant]
EP 2517828A1 · 2012 [cited by applicant]
JP 2011151352A · 2011 [cited by applicant]
WO 9858990A1 · 1998 [cited by applicant]
WO 2006032043A2 · 2006 [cited by applicant]
Technical Information, Aug. 2023, Kollidon, pp. 1-9 (Year: 2023). [cited by examiner]
Kazmierska, K, et al., Determination of urethral catheter surface lubricity, Journal of Materials Science: Materials m Medicine, vol. 19, No. 6,, pp. 2301-2306, published 2008. [cited by applicant]
Pharmaceutical Polymer Materials, Gao Feng, East China University of Science and Technology Press, 2014. 10, first edition, p. 96, 2014. [cited by applicant]
Jin Chang et al., ,PU/PVP Study on hydrophilic lubricity of semi-interpenetrating networks; China, Plastics, No. 12, pp. 29-33; 1999. [cited by applicant]
Office Action in Chinese Application No. 202080009044.4 dated Sep. 2, 2022 (providing concise explanation of Pharmaceutical Polymer Materials, Gao Feng, East China University of Science and Technology Press, 2014. 10, f… [cited by applicant]